Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
BMC Immunol ; 15: 32, 2014 Aug 31.
Article En | MEDLINE | ID: mdl-25174446

BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease characterized by the presence of allergic granulomatosis and necrotizing vasculitis with eosinophilic infiltration. The etiology of EGPA is unknown. Dendritic cells (DCs) are not only critical for the induction of primary immune responses; they may also be important for the induction of immunological tolerance and the regulation of the type of T-cell-mediated immune response. To investigate whether DC maturation is associated with EGPA disease status, we examined the relationship between the maturation of DCs and the differentiation of regulatory T (Treg) cells in EGPA patients. We exposed the CD14+ blood monocytes of 19 patients with EGPA in remission or relapse to stimulation with GM-CSF and IL-4 for 6 d and lipopolysaccharide for 24 h to obtain mature CD83+ DCs and immature CD206+ DCs. Using immunohistochemistry, we examined four patients for the presence of CD83+ and CD206+ DCs in the lung at the onset of EGPA. RESULTS: The percentage of CD83+ cells among DCs differentiated from CD14+ monocytes was lower for EGPA patients in relapse than in remission. The percentage of CD83+ DCs was inversely correlated with the percentage of CD206+ DCs and was significantly correlated with the numbers of naturally occurring CD4+ regulatory Treg (nTreg; FOXP3+CD4+) cells and inducible Treg (iTreg; CD4+CD25+ T cells producing IL-10 or TGF-ß) cells but not the number of eosinophils. The percentage of CD206+ DCs was significantly inversely correlated with the percentages of nTreg and iTreg cells but not the number of eosinophils. Immunohistochemistry revealed both CD206+ DCs and CD83+ DCs in alveoli and interstitial spaces at the onset of EGPA. CONCLUSION: The maturation of DCs from monocytes was related to disease activity in patients with EGPA. Increased CD83+ DCs in EGPA patients may induce the differentiation of iTreg and nTreg cells, thereby suppressing inflammation and disease activity.


Antigens, CD/metabolism , Churg-Strauss Syndrome/immunology , Dendritic Cells/pathology , Eosinophilic Granuloma/immunology , Immunoglobulins/metabolism , Membrane Glycoproteins/metabolism , T-Lymphocytes, Regulatory/immunology , Biopsy , Cell Count , Cell Differentiation/immunology , Churg-Strauss Syndrome/pathology , Eosinophilic Granuloma/pathology , Female , Humans , Immunohistochemistry , Interleukin-10/biosynthesis , Lung/immunology , Lung/pathology , Male , Middle Aged , Monocytes/cytology , Recurrence , Remission Induction , T-Lymphocytes, Regulatory/pathology , CD83 Antigen
2.
Neuropathology ; 34(1): 27-31, 2014 Feb.
Article En | MEDLINE | ID: mdl-23711133

It has been reported that abnormal processing of pre-mRNA is caused by abnormal triplet expansion. Non-coding triplet expansions produce toxic RNA to alter RNA splicing activities. However, there has been no report on the globular RNA aggregation in neuronal cytoplasmic inclusions (NCIs) up to now. We herein report on an autopsy case (genetically determined as spinocerebellar atrophy 8 (SCA8)) with hitherto undescribed NCIs throughout the brain. NCIs were chiefly composed of small granular particles, virtually identical to ribosomes. Neurological features are comparable to the widespread lesions of the brain, including the spinal cord. Although 1C2-positivity of NCIs might be induced by reverse transcription of the CTG expansion, it remains to be clarified how abnormal aggregations of ribosome and extensive brain degeneration are related to the reverse or forward transcripts of the expanded repeat.


Inclusion Bodies/ultrastructure , Neurons/ultrastructure , Spinocerebellar Ataxias/pathology , Adult , Cytoplasm/ultrastructure , DNA Repeat Expansion , Humans , Inclusion Bodies/genetics , Male , Spinocerebellar Ataxias/genetics
3.
Neuropathology ; 34(3): 304-8, 2014 Jun.
Article En | MEDLINE | ID: mdl-24354582

Adult-onset GM2 gangliosidosis is very rare and only three autopsy cases have been reported up to now. We report herein an autopsy case of adult-onset GM2 gangliosidosis. The patient developed slowly progressive motor neuron disease-like symptoms after longstanding mood disorder and cognitive dysfunction. He developed gait disturbance and weakness of lower limbs at age 52 years. Because of progressive muscle weakness and atrophy, he became bed-ridden at age 65. At age of 68, he died. His neurological findings presented slight cognitive disturbance, slight manic state, severe muscle weakness, atrophy of four limbs and no extrapyramidal signs and symptoms, and cerebellar ataxia. Neuropathologically, mild neuronal loss and abundant lipid deposits were noted in the neuronal cytoplasm throughout the nervous system, including peripheral autonomic neurons. The most outstanding findings were marked neuronal loss and distended neurons in the anterior horn of the spinal cord, which supports his clinical symptomatology of lower motor neuron disease in this case. The presence of lipofuscin, zebra bodies and membranous cytoplasmic bodies (MCB) and the increase of GM2 ganglioside by biochemistry led to diagnosis of GM2 gangliosidosis.


Gangliosidoses, GM2/complications , Gangliosidoses, GM2/pathology , Motor Neuron Disease/complications , Motor Neuron Disease/pathology , Aged , Autopsy , Diagnosis, Differential , Gangliosidoses, GM2/psychology , Humans , Male , Motor Neuron Disease/psychology
5.
Acta Neuropathol ; 105(5): 508-14, 2003 May.
Article En | MEDLINE | ID: mdl-12677452

Tau-like immunoreactivity (IR) on glial cytoplasmic inclusions (GCIs) of multiple system atrophy (MSA) was investigated with a panel of anti-tau antibodies and we found that tau2, one of the phosphorylation-independent antibodies, preferentially immunolabeled GCIs. Co-presence (0.03%) of polyethyleneglycol- p-isooctylphenyl ether (Triton X-100, TX) with tau2, however, abolished this IR on GCIs, but did not abolish tau2 IR on neurofibrillary tangles (NFTs). Tau2-immunoreactive bands on immunoblot of brain homogenates from MSA brains were retrieved mainly in a TRIS-saline-soluble fraction, as reported in normal brains. This was in contrast to SDS-soluble fractions from brain with Down's syndrome, which contained tau2-immunoreactive bands of higher molecular weight. It indicates that the appearance of tau2 IR on GCIs is not related to hyperphosphorylation of tau. These tau2-immunoreactive bands, except those from bovine brain, were similarly abolished in the presence of TX (0.06%), and repeated washing after exposure to TX restored the tau2 IR on immunohistochemistry and on immunoblot. These findings can be explained if the modified tau2 epitope undergoes a reversible conformational change on exposure to TX, which is reversible after washing. Because the conformation centered at Ser101 of bovine tau is crucial for its affinity to tau2, the Ser-like conformation mimicked by its human counterpart Pro may represent pathological modification of tau shared by GCIs and NFTs. The relative resistance of tau2 epitope on NFTs on exposure to TX suggests that tau woven into NFTs confers additional stability to the pathological conformation of tau2 epitope. The conformation of the tau2 epitope in GCIs is not as stable as in NFTs, suggesting that tau proteins are not the principal constituents of the fibrillary structures of GCIs, even though they were immunodecorated with tau2. The difference in the susceptibility of the tau2 epitope to TX may distinguish its conformational states, which are variously represented according to disease conditions.


Cytoplasm/metabolism , Detergents/pharmacology , Inclusion Bodies/metabolism , Multiple System Atrophy/metabolism , Neuroglia/metabolism , tau Proteins/chemistry , Aged , Brain/metabolism , Brain/ultrastructure , Cytoplasm/drug effects , Cytoplasm/ultrastructure , Epitopes/chemistry , Epitopes/drug effects , Female , Humans , Immunoblotting , Immunohistochemistry , Inclusion Bodies/chemistry , Inclusion Bodies/ultrastructure , Male , Microscopy, Immunoelectron , Middle Aged , Multiple System Atrophy/physiopathology , Neuroglia/drug effects , Neuroglia/ultrastructure , Peptide Fragments , Protein Conformation/drug effects
...